当前位置: 首页 > 详情页

Analysis of Renal Artery Stenosis in Patients with Heart Failure: A RASHEF Study

文献详情

资源类型:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C ◇ 中华系列

机构: [1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China; [2]Jiaonan Jianyu Hosp, Dept Cardiol, Jiaozuo 454000, Henan, Peoples R China; [3]Capital Med Univ, Dept Ultrasound, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Atherosclerosis Cardiac Dysfunction Heart Failure Renal Artery Stenosis

摘要:
Background: Previous data are controversial about the association of renal artery stenosis (RAS) with clinical outcome in patients with heart failure. Definition of RAS in previous studies might not be appropriate. By definition of RAS with renal duplex sonography, we investigated the association of RAS with clinical outcome in patients with heart failure. Methods: In this retrospective study, we identified 164 patients with heart failure (New York Heart Association classification >= II; left ventricular ejection fraction < 50%) who had received renal duplex sonography during hospital stay. RAS was defined as renal-aortic ratio >= 3.5 or a peak systolic velocity >= 200 cm/s (or both), or occlusion of the renal artery. Categorical data of patients were compared using the Chi-square test or Fishers exact test. Cox proportional hazards regression modeling technique was used to investigate the prognostic significance of possible predictors. Results: Finally, 143 patients were enrolled. Median follow-up time was 32 months (1-53 months). Twenty-two patients were diagnosed as RAS by renal duplex sonography, including 13 unilateral RAS (3 left RAS, 10 right RAS) and 9 bilateral RAS. There were more all-cause mortality and cardiovascular death in patients with RAS than patients without RAS. By multivariate analysis, RAS was a significant predictor for all-cause death and cardiovascular death (hazard ratio [HR] = 4.155, 95% confidence interval [CI]: 1.546-11.164, P = 0.005; and HR = 3.483, 95% CI: 1.200-10.104, P = 0.022, respectively). As for composite endpoint events, including death, nonfatal myocardial infarction, ischemic stroke or intracranial hemorrhage, rehospitalization for cardiac failure, and renal replacement therapy, only angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker was significant predictor. RAS was not a significant predictor for composite endpoint events. Conclusions: Our data suggested that RAS is associated with a poorer clinical outcome in patients with heart failure.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 医学:内科
JCR分区:
出版当年[2013]版:
Q3 MEDICINE, GENERAL & INTERNAL
最新[2024]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Dept Cardiol, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18225 今日访问量:1 总访问量:998 更新日期:2025-10-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院